| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigations |
1 Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
2 Department of Gynecology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
4 Departmentof Obstetrics and Gynecology, Sapir Medical Center, Kfar Sava, Israel
The purpose of the study was to assess physiologic endometrial 18F-FDG uptake during the 4 phases of the menstrual cycle and to differentiate between physiologic and malignant endometrial uptake. Methods: Endometrial 18F-FDG uptake, expressed as standardized uptake value (SUV), was measured on PET/CT images of 285 consecutive female patients, of whom 246 (112 premenopausal and 134 postmenopausal) had no known gynecologic malignancy and 39 (14 premenopausal and 25 postmenopausal) had cervical, endometrial, or ovarian cancer. Results: Two peaks of increased endometrial 18F-FDG uptake were identified during the 4-phase cycle. The mean SUVs were 5 ± 3.2 and 3.7 ± 0.9 in menstruating and ovulating patients, respectively, and 2.6 ± 1.1 and 2.5 ± 1.1 in patients in the proliferative and secretory phases, respectively. The mean endometrial SUV in postmenopausal patients not receiving hormonal therapy was 1.7 ± 0.5. Oligomenorrhea and benign endometrial abnormalities were associated with increased 18F-FDG uptake. Neither contraceptives nor hormonal therapy was associated with a significant increase in endometrial uptake. In addition to the increased tumor uptake measured in patients with cervical cancer (14.9 ± 7.3 in postmenopausal patients and 12.2 ± 6.6 in premenopausal patients), increased uptake was also found in the adjacent endometrium, although it appeared normal on CT (4.8 ± 2 in premenopausal patients and 4.7 ± 2.8 in postmenopausal patients). Increased ovarian 18F-FDG uptake was detected in 7 patients with ovarian cancer (9.1 ± 4) and in 21 premenopausal patients without known ovarian malignancy (5.7 ± 1.5, P < 0.01), of whom 15 were at mid cycle and 3 reported oligomenorrhea. An ovarian SUV of 7.9 separated benign from malignant uptake with a sensitivity of 57% and a specificity of 95%. Conclusion: In premenopausal patients, normal endometrial uptake of 18F-FDG changes cyclically, increasing during the ovulatory and menstrual phases. Increased uptake in the endometrium adjacent to a cervical tumor does not necessarily reflect endometrial tumor invasion. Increased ovarian uptake in postmenopausal patients is associated with malignancy, whereas increased ovarian uptake may be functional in premenopausal patients.
Key Words: 18F-FDG • physiologic uptake • endometrium • cervical cancer • PET/CT
This article has been cited by other articles:
|
|
 |
|
  T. Tsujikawa, Y. Yoshida, T. Mori, T. Kurokawa, Y. Fujibayashi, F. Kotsuji, and H. Okazawa Uterine Tumors: Pathophysiologic Imaging with 16{alpha}-[18F]fluoro-17{beta}-estradiol and 18F Fluorodeoxyglucose PET--Initial Experience Radiology, August 1, 2008; 248(2): 599 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Milam, M. R. Milam, and R. B. Iyer Detection of Early-Stage Ovarian Cancer by FDG-PET-CT in a Patient With BRCA2-Positive Breast Cancer J. Clin. Oncol., December 10, 2007; 25(35): 5657 - 5658. [Full Text] [PDF]
|
|
|
|
 |
|
 S Basu, N Nair, and N S Baghel A hypermetabolic abdominal focus in a case of osteogenic sarcoma on 18FDG-PET: in vivo insight into the gravid myometrial metabolism pattern Br. J. Radiol., October 1, 2007; 80(958): 851 - 852. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Blake, A. Singh, B. N. Setty, J. Slattery, M. Kalra, M. M. Maher, D. V. Sahani, A. J. Fischman, and P. R. Mueller Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT RadioGraphics, September 1, 2006; 26(5): 1335 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Zissin, U Metser, H Lerman, G Lievshitz, T Safra, and E Even-Sapir PET-CT findings in surgically transposed ovaries Br. J. Radiol., February 1, 2006; 79(938): 110 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. von Schulthess, H. C. Steinert, and T. F. Hany Integrated PET/CT: Current Applications and Future Directions Radiology, February 1, 2006; 238(2): 405 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sella, S. Mironov, and H. Hricak Reply Am. J. Roentgenol., January 1, 2006; 186(1): 268 - 268. [Full Text] [PDF]
|
|
|
|
|
|
R. Zissin and E. Even-Sapir 18F-FDG Uptake on PET/CT in Transposed Ovaries Am. J. Roentgenol., January 1, 2006; 186(1): 267 - 268. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pandit-Taskar Oncologic Imaging in Gynecologic Malignancies J. Nucl. Med., November 1, 2005; 46(11): 1842 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ames, T. Blodgett, and C. Meltzer 18F-FDG Uptake in an Ovary Containing a Hemorrhagic Corpus Luteal Cyst: False-Positive PET/CT in a Patient with Cervical Carcinoma Am. J. Roentgenol., October 1, 2005; 185(4): 1057 - 1059. [Full Text] [PDF]
|
|
|
|
|
|
N. Subhas, P. V. Patel, H. K. Pannu, H. A. Jacene, E. K. Fishman, and R. L. Wahl Imaging of Pelvic Malignancies with In-Line FDG PET-CT: Case Examples and Common Pitfalls of FDG PET RadioGraphics, July 1, 2005; 25(4): 1031 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K-C Ho, K-K Ng, T-C Yen, and H-H Chou An ovary in luteal phase mimicking common iliac lymph node metastasis from a primary cutaneous peripheral primitive neuroectodermal tumour as revealed by 18-fluoro-2-deoxyglucose positron emission tomography Br. J. Radiol., April 1, 2005; 78(928): 343 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Even-Sapir, Y. Parag, H. Lerman, M. Gutman, C. Levine, M. Rabau, A. Figer, and U. Metser Detection of Recurrence in Patients with Rectal Cancer: PET/CT after Abdominoperineal or Anterior Resection Radiology, September 1, 2004; 232(3): 815 - 822. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
